Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 32.7 M37.24 M34.96 M36.17 M 141.06 M Research & development ———— — Operating income -4.74 M24.15 M36.31 M37.06 M 92.78 M Non-Operating Income, Total -80 K261 K-78 K399 K 502 K Interest expense, net of interest capitalized 769 K684 K917 K562 K 2.93 M Non-Operating Income, excl. Interest Expenses -769 K-684 K-917 K-562 K -2.93 M Unusual income/expense -80 K261 K-78 K399 K 502 K Pretax income -17.26 M12.3 M10.03 M21.34 M 26.42 M Equity in earnings ———— — Taxes -7.77 M6.16 M7.92 M-9.04 M -2.73 M Non-controlling/minority interest 42 K49 K15 K201 K 307 K After tax other income/expense ———— — Net income before discontinued operations -9.53 M6.1 M2.1 M30.18 M 28.85 M Discontinued operations ———— — Net income -9.53 M6.1 M2.1 M30.18 M 28.85 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -9.53 M6.1 M2.1 M30.18 M 28.85 M Basic earnings per share (Basic EPS) -0.090.060.020.34 0.33 Diluted earnings per share (Diluted EPS) -0.090.060.020.34 0.33 Average basic shares outstanding 100.79 M100.94 M88.65 M90 M — Diluted shares outstanding 100.79 M101.48 M88.99 M90.3 M — EBITDA 61.74 M92.96 M102.6 M113.5 M 370.8 M EBIT 24.56 M56.12 M65.9 M56.58 M 203.16 M Cost of revenue 687.42 M892.84 M772.08 M778.13 M 3.13 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 37.17 M36.84 M36.7 M56.92 M 167.64 M